Belvedere Center, Genesis Healthcare, The | |
2507 Chestnut Street, Chester, Pennsylvania 19013 | |
(610) 872-5373 | |
Name | Belvedere Center, Genesis Healthcare, The |
---|---|
Location | 2507 Chestnut Street, Chester, Pennsylvania |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 150 |
Occupancy Rate | 80.07% |
Medicare ID (CCN) | 395595 |
Legal Business Name | 2507 Chestnut Street Operations Llc |
Ownership Type | For Profit - Corporation |
NPI Number | 1043520638 |
Organization Name | GENESIS |
Address | 2507 Chestnut St, Chester, PA 19013 |
Phone Number | 610-872-5373 |
News Archive
Vical Incorporated announced the publication in the June issue of Melanoma Research of updated data from the company's Phase 2 trial of high-dose (2 mg) Allovectin-7® in patients with metastatic melanoma. A separate article in the May issue of Expert Opinion on Biological Therapy reviewed results from the Phase 2 trial and previous clinical studies of Allovectin-7®.
Scientists who pioneered sequencing the genomes of cancer patients to find novel genetic changes at the root of the disease now have turned their attention to a laboratory workhorse — a mouse.
Senate majority leader becomes the latest prominent Democrat to express concerns about the roll-out of the law, placing blame on Obama administration and on Republicans for resisting adequate funding.
Dr. Yuri Lvov, professor of chemistry and T. Pipes Eminent Endowed Chair in Micro and Nanosystems at Louisiana Tech University's Institute for Micromanufacturing, has been selected to receive the prestigious Humboldt Research Award in chemistry, also known as the Humboldt Prize, by the Alexander von Humboldt Foundation in Germany.
› Verified 3 days ago
NPI Number | 1568644953 |
Organization Name | 2507 CHESTNUT STREET OPERATIONS LLC |
Doing Business As | THE BELVEDERE CENTER |
Address | 2507 Chestnut St, Chester, PA 19013 |
Phone Number | 610-872-5373 |
News Archive
Vical Incorporated announced the publication in the June issue of Melanoma Research of updated data from the company's Phase 2 trial of high-dose (2 mg) Allovectin-7® in patients with metastatic melanoma. A separate article in the May issue of Expert Opinion on Biological Therapy reviewed results from the Phase 2 trial and previous clinical studies of Allovectin-7®.
Scientists who pioneered sequencing the genomes of cancer patients to find novel genetic changes at the root of the disease now have turned their attention to a laboratory workhorse — a mouse.
Senate majority leader becomes the latest prominent Democrat to express concerns about the roll-out of the law, placing blame on Obama administration and on Republicans for resisting adequate funding.
Dr. Yuri Lvov, professor of chemistry and T. Pipes Eminent Endowed Chair in Micro and Nanosystems at Louisiana Tech University's Institute for Micromanufacturing, has been selected to receive the prestigious Humboldt Research Award in chemistry, also known as the Humboldt Prize, by the Alexander von Humboldt Foundation in Germany.
› Verified 3 days ago
NPI Number | 1609199561 |
Organization Name | GENESIS REHAB SERVICES |
Address | 2507 Chestnut St, Chester, PA 19013 |
Phone Number | 610-872-5373 |
News Archive
Vical Incorporated announced the publication in the June issue of Melanoma Research of updated data from the company's Phase 2 trial of high-dose (2 mg) Allovectin-7® in patients with metastatic melanoma. A separate article in the May issue of Expert Opinion on Biological Therapy reviewed results from the Phase 2 trial and previous clinical studies of Allovectin-7®.
Scientists who pioneered sequencing the genomes of cancer patients to find novel genetic changes at the root of the disease now have turned their attention to a laboratory workhorse — a mouse.
Senate majority leader becomes the latest prominent Democrat to express concerns about the roll-out of the law, placing blame on Obama administration and on Republicans for resisting adequate funding.
Dr. Yuri Lvov, professor of chemistry and T. Pipes Eminent Endowed Chair in Micro and Nanosystems at Louisiana Tech University's Institute for Micromanufacturing, has been selected to receive the prestigious Humboldt Research Award in chemistry, also known as the Humboldt Prize, by the Alexander von Humboldt Foundation in Germany.
› Verified 3 days ago
NPI Number | 1619922267 |
Organization Name | GENESIS ELDERCARE CENTERS BELVEDERE INC |
Doing Business As | THE BELVEDERE CENTER |
Address | 2507 Chestnut St, Chester, PA 19013 |
Phone Number | 610-872-5373 |
News Archive
Vical Incorporated announced the publication in the June issue of Melanoma Research of updated data from the company's Phase 2 trial of high-dose (2 mg) Allovectin-7® in patients with metastatic melanoma. A separate article in the May issue of Expert Opinion on Biological Therapy reviewed results from the Phase 2 trial and previous clinical studies of Allovectin-7®.
Scientists who pioneered sequencing the genomes of cancer patients to find novel genetic changes at the root of the disease now have turned their attention to a laboratory workhorse — a mouse.
Senate majority leader becomes the latest prominent Democrat to express concerns about the roll-out of the law, placing blame on Obama administration and on Republicans for resisting adequate funding.
Dr. Yuri Lvov, professor of chemistry and T. Pipes Eminent Endowed Chair in Micro and Nanosystems at Louisiana Tech University's Institute for Micromanufacturing, has been selected to receive the prestigious Humboldt Research Award in chemistry, also known as the Humboldt Prize, by the Alexander von Humboldt Foundation in Germany.
› Verified 3 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Vical Incorporated announced the publication in the June issue of Melanoma Research of updated data from the company's Phase 2 trial of high-dose (2 mg) Allovectin-7® in patients with metastatic melanoma. A separate article in the May issue of Expert Opinion on Biological Therapy reviewed results from the Phase 2 trial and previous clinical studies of Allovectin-7®.
Scientists who pioneered sequencing the genomes of cancer patients to find novel genetic changes at the root of the disease now have turned their attention to a laboratory workhorse — a mouse.
Senate majority leader becomes the latest prominent Democrat to express concerns about the roll-out of the law, placing blame on Obama administration and on Republicans for resisting adequate funding.
Dr. Yuri Lvov, professor of chemistry and T. Pipes Eminent Endowed Chair in Micro and Nanosystems at Louisiana Tech University's Institute for Micromanufacturing, has been selected to receive the prestigious Humboldt Research Award in chemistry, also known as the Humboldt Prize, by the Alexander von Humboldt Foundation in Germany.
› Verified 3 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 22.41 | 14.46 |
Percentage of long-stay residents who lose too much weight | 9.41 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 29.51 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.55 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 0.92 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 2.32 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 1.35 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 90.36 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 16.44 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 70.59 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 1.49 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 32.93 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 18.01 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 7.05 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 97.22 | 95.98 |
Percentage of short-stay residents who made improvements in function | 65.26 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 73.28 | 82.93 |
News Archive
Vical Incorporated announced the publication in the June issue of Melanoma Research of updated data from the company's Phase 2 trial of high-dose (2 mg) Allovectin-7® in patients with metastatic melanoma. A separate article in the May issue of Expert Opinion on Biological Therapy reviewed results from the Phase 2 trial and previous clinical studies of Allovectin-7®.
Scientists who pioneered sequencing the genomes of cancer patients to find novel genetic changes at the root of the disease now have turned their attention to a laboratory workhorse — a mouse.
Senate majority leader becomes the latest prominent Democrat to express concerns about the roll-out of the law, placing blame on Obama administration and on Republicans for resisting adequate funding.
Dr. Yuri Lvov, professor of chemistry and T. Pipes Eminent Endowed Chair in Micro and Nanosystems at Louisiana Tech University's Institute for Micromanufacturing, has been selected to receive the prestigious Humboldt Research Award in chemistry, also known as the Humboldt Prize, by the Alexander von Humboldt Foundation in Germany.
› Verified 3 days ago
Belvedere Center, Genesis Healthcare, The Location: 2507 Chestnut Street, Chester, Pennsylvania 19013 Phone: (610) 872-5373 |